https://www.selleckchem.com/pr....oducts/methyl-b-cycl
In Multiple Sclerosis (MS) women, therapeutic management for pregnancy planning and during pregnancy still represents a challenge regarding timing of disease-modifying therapies (DMT) stop, risk of disease reactivation and potential fetal toxicity. The objective of this study was to describe disease activity during pregnancy and postpartum depending on treatment status before conception in women with MS. 339 MS patients who have achieved a pregnancy between 2007 and 2017 were included. Women were classified according to th
Like
Comment
Share
